Share tips of the week
MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
Three to buy
Aviva
(Shares) Aviva has reported “robust” half-year results and reinstated its dividend. Yet shares in the insurer trade on just 6.5 times forward earnings, one of the lowest ratings in the FTSE 100. That looks unjustified. New boss Amanda Blanc is refocusing the business on core markets in the UK, Ireland and Canada and has already sold the “prized” Singapore operation for £1.6bn. The cash will help Aviva to reduce leverage and the strategy should ultimately pave the way for higher investor returns. 301p
Domino’s Pizza
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
(The Sunday Telegraph) Recent coverage of this pizza chain has been dominated by spats between management and franchisees about the pace of new store openings. However, lockdown gave both sides a slice of the action as housebound consumers turned to food delivery. That generated a 3.7% jump in first-half underlying sales and could help ease the way to better relations in the future. The shares are worth a bite. 341.75p
Ocado
(The Mail on Sunday) Ocado’s shares are expensive and the company is loss-making. But lockdown seems to have shifted shopping habits, with consumers still ordering online at an “unprecedented rate”. A new partnership with Marks & Spencer is going well, coinciding with a 52% leap in third quarter revenue. It is also partnering with big supermarkets in the US and France for their online operations. With a grim “stay-at-home winter” looming, the attractions of the virtual checkout will grow. 2,817p
Three to sell
Premier Oil & Tullow Oil
(Interactive Investor) Weak oil prices have turned these two independent oil producers into “proverbial ‘zombies’” – companies that are using debt to stay afloat while praying that oil prices improve. That hasn’t stopped speculative fever – both saw their share prices more than triple between March and mid-June. Yet renewed doubts about global demand for “black gold” this autumn have seen those gains unwind while interim results have been little short of “carnage”. Such volatile, “snakes and ladders” shares are not for long-term investors, so steer clear. 17.5p and 15p
The Hut Group
(The Evening Standard) Investors have piled into this newly floated e-commerce specialist, which sells everything from mascara to sports nutrition products. The e-commerce outsourcing arm Ingenuity is an especially compelling growth play. Yet this float has “got more red flags than Tiananmen Square”. All the big banks are involved in the IPO so there are few sceptics to be found, while early backer KKR is selling all of its stake, which is hardly a ringing endorsement. The post-float corporate governance arrangements are also “all over the place”. Wait six months to see how things “settle” before putting any of your own money on the line. 610p
Greencore
(The Times) This Irish convenience-food group was in a sweet spot. Then the pandemic struck, keeping people stuck at home and making their own sandwiches. The group’s food-to-go revenue halved between late March and June and its “convalescence” is proving slow going. Food-processing plants are also vulnerable to virus outbreaks. Avoid. 111.25p
...and the rest
The Daily Telegraph
Wind power requires big, complex machinery, which keeps new entrants out of the market. That has ensured fast-rising profits for Danish renewables pioneer Vestas (DKr948.8). Motoring accident credit and legal specialist Anexo could prove a bargain at the current valuation (127.5p).
Investors Chronicle
Shares in Adobe have been swept up by this year’s US tech surge but even on 48 times forecast earnings they are still a buy: this business combines the reliable cash-generation of an established name with the growth prospects of a digital play ($471). Hurricanes and wildfires have left many Americans in the dark this year. That should bring rising demand for back-up power specialist Generac ($184).
The Mail on Sunday
Aim-listed online mattress seller Eve Sleep has been a “nightmare” investment in recent years but a 25% sales jump in the second quarter suggests that it is well-placed to capitalise if a “miserable winter” keeps families out of physical stores (4.85p).
Shares
Shares in audio technology play Focusrite are up by almost one-fifth since July and should continue to rise on the back of structural tailwinds (819p). Smart Metering Systems has been resilient this year. Hold for the generous dividend policy (660p).
The Times
Premium drinks maker Fever-Tree is going from strength to strength and has room to expand in the United States (2,183p). Loungers, which operates café bar chains, is well-placed to flourish when life returns to normal (170p).
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
-
8 of the best houses for sale with annexes
The best houses with annexes – from a period property in the Lake District to a 13th-century house with a two-bedroom annexe in Saltwood, Kent
By Natasha Langan Published
-
Zelenskyy moves to appease Donald Trump – what happens now?
Ukraine’s president Volodymyr Zelenskyy is conceding ground to secure the least-worst deal possible, says Emily Hohler
By Emily Hohler Published
-
Rolls-Royce stock jumps 15% – could it climb further?
Aircraft-engine group Rolls-Royce’s CEO has been hailed as a hero for spearheading the firm’s recovery. And the future looks bright, says Matthew Partridge
By Dr Matthew Partridge Published
-
The power of private markets
Interview Helen Steers, co-manager of the Pantheon International investment trust, tells MoneyWeek about the vast array of compelling opportunities in private equity
By Andrew Van Sickle Published
-
Vertex Pharmaceuticals is an uncommon opportunity in rare diseases
Vertex Pharmaceuticals operates in a profitable subsector and is poised for further success
By Dr Mike Tubbs Published
-
Global investors have overlooked these top tips in emerging markets
Opinion Chris Tennant, co-portfolio manager of Fidelity Emerging Markets, picks three attractive companies in emerging markets
By Chris Tennant Published
-
King Coal has not been dethroned yet — should you buy?
The demand for coal is only growing, yet investors don’t seem to want to take advantage of the opportunity, says Rupert Hargreaves
By Rupert Hargreaves Published
-
It’s time to start buying Europe again, says Merryn Somerset Webb
Opinion Europe's stocks are cheap and the economic backdrop is starting to look cheerier, says Merryn Somerset Webb
By Merryn Somerset Webb Published
-
Prosus to buy Just Eat for €4.1 billion as takeaway boom fades
Food-delivery platform Just Eat has been gobbled up by a Dutch rival. Now there could be further consolidation in the sector
By Dr Matthew Partridge Published
-
Should investors stay bullish and buy UK and US stocks?
Opinion Ignore the Eeyores, says Max King. The outlook for stocks in both Britain and America remains auspicious
By Max King Published